Spots Global Cancer Trial Database for Intensified Rituimab Prephase Before FCR in Untreated B-CLL
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Intensified Rituimab Prephase Before FCR in Untreated B-CLL
Official Title: Phase II Multicentric, Randomized Trial, Exploring Intensified Rituximab Prephase Monotherapy Before Standard Fludarabine-Cyclophosphamide-Rituximab Regimen in Previously Untreated Symptomatic B-cell Chronic Lymphocytic Leukemia
Study ID: NCT01370772
Conditions
Study Description
Brief Summary: Phase II, multicenter, randomized trial, exploring intensified Rituximab prephase monotherapy before standard Fludarabine-Cyclophosphamide-Rituximab FC-R regimen in previously untreated symptomatic B-cell chronic lymphocytic leukemia CLL. A Study from the Goelams GCFLLCMW intergroup
Detailed Description: Young fit medically B Cell untreated patients Comparison between FCR treatment = 6 FCR cycles and a the addition of a prephase with R Dense treatment before the 6 FCR cycles.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stephane LEPRETRE, Rouen, CLCC Henri Becquerel, France
Guillaume CARTRON, Montpellier, Regional university Hospital, France
Contact Details
Name: Guillaume CARTRON, MD PD
Affiliation: French Innovative Leukemia Organisation
Role: PRINCIPAL_INVESTIGATOR
Name: Stephane LEPRETRE, MD
Affiliation: French Innovative Leukemia Organisation
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
